Arrowpoint Investment Partners’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
FLAM
PCH
AIM
WA
Arrowpoint Investment Partners's AXGN Position: Q2 2026 in Review
Arrowpoint Investment Partners sold out of Axogen (AXGN) in Q2 2026, closing a stake of 16,273 shares — an estimated $539K sold.
Arrowpoint Investment Partners first reported a position in AXGN in Q4 2025 and held it in 2 quarters. The position peaked at $628K in Q4 2025. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.
- Arrowpoint Investment Partners reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
- Arrowpoint Investment Partners sold 16,273 Axogen shares in Q2 2026, an estimated $539K.
- Arrowpoint Investment Partners first reported a position in Axogen in Q4 2025 and held it in 2 quarters.
- Arrowpoint Investment Partners's Axogen position peaked at $628K in Q4 2025.
- 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.
Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.